These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


220 related items for PubMed ID: 18988557

  • 1. Coming soon to your lab: NAF for breast-cancer risk assessment.
    Bentz J.
    MLO Med Lab Obs; 2008 Oct; 40(10):52-3. PubMed ID: 18988557
    [No Abstract] [Full Text] [Related]

  • 2. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
    Visvanathan K, Santor D, Ali SZ, Brewster A, Arnold A, Armstrong DK, Davidson NE, Helzlsouer KJ.
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):950-5. PubMed ID: 17507621
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
    Masood S.
    Clin Lab Med; 2005 Dec; 25(4):827-43, viii-ix. PubMed ID: 16308095
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Patient variables that predict atypical cytology by nipple duct lavage.
    Bushnaq ZI, Ashfaq R, Leitch AM, Euhus D.
    Cancer; 2007 Apr 01; 109(7):1247-54. PubMed ID: 17326050
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ductal lavage and its histopathologic basis: a cautionary tale.
    Badve S.
    Diagn Cytopathol; 2004 Mar 01; 30(3):166-71. PubMed ID: 14986296
    [Abstract] [Full Text] [Related]

  • 9. Molecular analysis of nipple fluid for breast cancer screening.
    Suijkerbuijk KP, van der Wall E, Vooijs M, van Diest PJ.
    Pathobiology; 2008 Mar 01; 75(2):149-52. PubMed ID: 18544970
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nipple aspirate cytology for the study of breast cancer precursors.
    King EB, Chew KL, Petrakis NL, Ernster VL.
    J Natl Cancer Inst; 1983 Dec 01; 71(6):1115-21. PubMed ID: 6581355
    [Abstract] [Full Text] [Related]

  • 12. Editorial: ductal lavage of the breast.
    Linder J.
    Diagn Cytopathol; 2004 Mar 01; 30(3):140-2. PubMed ID: 14986292
    [No Abstract] [Full Text] [Related]

  • 13. Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry.
    He J, Gornbein J, Shen D, Lu M, Rovai LE, Shau H, Katz J, Whitelegge JP, Faull KF, Chang HR.
    Int J Oncol; 2007 Jan 01; 30(1):145-54. PubMed ID: 17143523
    [Abstract] [Full Text] [Related]

  • 14. Ductal lavage and risk assessment of breast cancer.
    Arun B.
    Oncologist; 2004 Jan 01; 9(6):599-605. PubMed ID: 15561804
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of nipple-aspirate fluid cytology in breast-cancer risk screening.
    Bentz J.
    MLO Med Lab Obs; 2009 Mar 01; 41(3):8, 10, 12-7. PubMed ID: 19374177
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nipple fluid cytology.
    Masood S, Khalbuss WE.
    Clin Lab Med; 2005 Dec 01; 25(4):787-94, vii-viii. PubMed ID: 16308092
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.